LONDON, LONDON, UNITED KINGDOM, January 2, 2019 /EINPresswire.com/ — SMi Report: An exclusive interview with Marine Marius, Scientist, Analytical Research and Development Europe, Sanofi Pasteur just ahead of the 8th Annual Pharmaceutical Microbiology UK conference, taking place in January 2019.
The 8th Annual Pharmaceutical Microbiology UK, will debut in London, on 21 and 22 January 2019. With less than a month remaining, both the pharmaceutical and specialty chemicals industries currently facing both unparalleled opportunities and challenges will gather to address the key trends, challenges and strategies in contamination control.
If you attend the conference, you will gain insight into:
• Challenges in development of a contamination control strategy for different product types
• A series of learning experiences within contamination from Boehringer Ingelheim
• The use of vaporised hydrogen peroxide bio-decontamination technology in microbiology contamination control
• Case studies in deinococcus and fungal and bacterial spores in cleanrooms
• Influence of temperature of incubation on results of microbiological environmental monitoring
• Risk mitigation strategies for animal-derived raw materials
Just under three weeks to go for the conference SMi caught up with Marine Marius, Scientist, Analytical Research and Development Europe at Sanofi Pasteur. Below is a small snippet from her interview below:
What developments within contamination control have really caught your eye in the past year? “These are all dynamic approaches from process analytical technology environment such as on-line bioburden. These approaches aim to produce products with consistent quality and to improve pharma's productivity and environmental impact.”
How would you describe the current challenges in the pharmaceutical microbiology industry? “To me, the current challenges concern the implementation of new technologies with different outcomes of results (e.g. CFU vs cell in FCM) and the difficulty to link to current pharmacopeia.”
To read Marine Marius’s full speaker interview and more exclusive content, please visit the Download Centre at http://www.pharma-microbiology.com/pr3.
Pharmaceutical Microbiology UK attendees will have access to network with companies across the complete pharma supply chain. With its unique blend of unprecedented global influence and the infrastructure to advance relationships between buyers and sellers, Pharmaceutical Microbiology UK will provide a platform of solutions and ideas unlike any other.
Pharmaceutical Microbiology UK is proudly sponsored by Gold Sponsor: DuPont and Sponsors: Mettler Toledo, bioMérieux, Copan Group & Fujifilm
Sponsorship has sold out, but you can still contact Alia Malick, Director at SMi on +44 (0) 20 827 6168 or firstname.lastname@example.org to discuss related event packages that are available.
For media enquiries contact Simi Sapal on +44 (0) 20 7827 6000 or email@example.com.
Pharmaceutical Microbiology 2019
Conference: 21st – 22nd January 2019
Post-conference workshop: 23rd January 2019
Copthorne Tara Hotel, London, UK
Follow us @SMiPharm
—- END —-
About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
email us here
Source: EIN Presswire